Outbreaks of highly pathogenic avian influenza \(HPAI\), infecting birds, livestock, and recently humans in the U.S., have heightened concerns of a potential escalation into a pandemic. The U.S. CDC maintains that the risk to the public is low, and they continue to monitor the situation closely. Our role as a global leader in pandemic influenza preparedness is to treat pandemics as a matter of “when,” not “if.” We are a proud champion of pandemic preparedness and recognize that the combination of surveillance, testing, and vaccine protection provides pandemic preparedness reassurance to governments and populations around the world. At CSL Seqirus, we remain at the front line of public health and will persist in closely monitoring the avian influenza developments in collaboration with our global partners. Read more about our position on pandemic preparedness: https://bit.ly/3yO6pIA #CSLSeqirus #DrivenByOurPromise
CSL Seqirus Announces U.S. Government Award in Response to Avian Influenza
CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government’s outbreak and preparedness response.
CSL has Announced its 2024 Half Year Financial Results. Click here to read more →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia